ArticleAntimicrobial resistance and infection control2020
Antibiogram and beta-lactamase genes among cefotaxime resistant E. coli from wastewater treatment plant.
Article in Antimicrobial resistance and infection control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 45 citations in OpenAlex.
- Phenotypic and molecular characterization of cefotaxime-resistant Klebsiella pneumoniae from chicken litter of selected farms in Uganda.BMC research notes · 2026Article
- Antibiotic Resistance and Phylogenetic Diversity ofMicroorganisms · 2026Article
- Antimicrobial resistance profiling of Salmonella and Escherichia coli isolates from conventional poultry farms in Hossana Town, Central Ethiopia.BMC veterinary research · 2025Article
- Molecular characterization of extended spectrum beta lactamase producing Escherichia coli in two different wastewater treatment plants in Hatay Province, Türkiye.Scientific reports · 2025Article
- Multidrug-resistant E. Coli in wastewater sources: a comparative study and identification of resistance hotspots.BMC microbiology · 2025Article
- Synergistic removal of emerging contaminants using bacterial augmented floating treatment bed system (FTBs) ofFrontiers in microbiology · 2025Article
- Third-Generation Cephalosporin-Resistant UropathogenicThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025Article
- Comparison of methods proposed for monitoring cefotaxime-resistantApplied and environmental microbiology · 2024Article
- Comparison of Cefotaxime-ResistantAntibiotics (Basel, Switzerland) · 2023Article
- Antimicrobial Resistance Profiles and Co-Existence of Multiple Antimicrobial Resistance Genes inAntibiotics (Basel, Switzerland) · 2023Article
- The African Wastewater Resistome: Identifying Knowledge Gaps to Inform Future Research Directions.Antibiotics (Basel, Switzerland) · 2023Review
- Antimicrobial resistance genes ofAIMS microbiology · 2023Review
- Clinically Relevant β-Lactam Resistance Genes in Wastewater Treatment Plants.International journal of environmental research and public health · 2022Review
- Carbapenem resistance associated with coliuria among outpatient and hospitalised urology patients.New microbes and new infections · 2022Article
- Assessment of well water as a reservoir for extended-spectrum β-lactamases (ESBL) and carbapenem resistantIranian journal of microbiology · 2022Article
- Temporal Variation of Meropenem Resistance inAntibiotics (Basel, Switzerland) · 2022Article
- Similarities in Virulence and Extended Spectrum Beta-Lactamase Gene Profiles among Cefotaxime-ResistantAntibiotics (Basel, Switzerland) · 2022Article
- Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis.FEMS microbiology reviews · 2022Review
- Occurrence and removal of antibiotics, antibiotic resistance genes, and bacterial communities in hospital wastewater.Environmental science and pollution research international · 2021Article
- New Insight on Antibiotic Resistance and Virulence ofAntibiotics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe World Health Organization (WHO) recently classified Enterobacteriaceae resistance to third-generation cephalosporin into the group of pathogens with critical criteria for future research.
methodsA study to assess the antibiogram and beta-lactamase genes among the cefotaxime resistant E. coli (CREc) from a South African wastewater treatment plant (WWTP) was conducted using standard phenotypic and molecular biology characterization methods.
resultsApproximate total E. coli (TEc) concentration (log
conclusionResistance to cefotaxime and the presence of a wide range of beta-lactamase genes exposed the potential risks associated with these pathogens via occupational and domestic exposure during the reuse of treated wastewater.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.